Table 3.

Radiation and bortezomib: ongoing studies

PhaseCombinationTumor type
IBortezomib and concurrent external beam radiationAdvanced solid tumors
I/IIBortezomib in combination with paclitaxel /carboplatin and radiationLung (NSCLC)
IBortezomib and radiation therapyHead and neck, central nervous system, cervix
IBortezomib and radiation therapyRecurrent metastatic head and neck
IBortezomib and paclitaxel with radiationBiliary tract, pancreas
IIBortezomib and cisplatin/etoposide with radiationSCLC